$JYNT Cashflow Statement | Understand Stock

$JYNT

$7.26 +$0.04 (0.62%) Close

$JYNT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
Net loss on disposition or impairment (non-cash portion)
Net loss on disposition or impairment
Net franchise fees recognized upon termination of franchise agreements
Deferred income taxes
Provision for credit losses
Stock-based compensation expense
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Deferred franchise costs
Deposits and other assets
Accounts payable
Accrued expenses
Payroll liabilities
Operating leases
Deferred revenue
Upfront regional developer fees
Other liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Acquisition
AZ Clinics
NC Clinics
CA clinics
Total acquisition
Proceeds from sale of clinics
Purchase of property and equipment
Reacquisition and termination of regional developer rights
Payments received on notes receivable
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Payments of finance lease obligations
Purchases of treasury stock under employee stock plans
Purchases of common stock under stock repurchase programs
Proceeds from exercise of stock options
Proceeds from the Credit Agreement, net of related fees
Proceeds from the Paycheck Protection Program
Repayment of Debt under the Credit Agreement
Net cash used in financing activities

(Decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Supplemental cash flow disclosures:
Net cash paid for:
Interest
Income taxes
Non-cash investing and financing activity:
Unpaid purchases of property and equipment
Stock option exercise receivable
Non-cash investment in acquisition of franchised clinics
Franchise Fees Collected Upon Franchise Agreement
Total non-cash investment in acquisition of franchised clinics
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash

Comments